# DESCRIPTION

## FIELD OF THE INVENTION

- relate to primer(s), probes, method(s), and kit(s) for Influenza A virus detection

## BACKGROUND TO THE INVENTION

- introduce Influenza A virus and its subtypes
- describe mutation and evolution of Influenza A virus
- discuss oseltamivir resistance in H1N1
- highlight importance of early detection and treatment

## SUMMARY OF THE INVENTION

- motivate early detection and treatment of Influenza A virus
- introduce molecular biology techniques for detection
- highlight importance of sensitive and specific detection methods
- describe severity of Influenza A (H1N1) 2009
- introduce oligonucleotides for detecting Influenza A virus
- describe advantages of oligonucleotides
- highlight importance of specific and/or sensitive detection methods

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

- define terms used in the invention

### DEFINITIONS

- define biological sample
- define complementary
- define comprising
- define derivative
- define fragment
- define H275Y
- define internal control molecule
- define influenza virus
- define mutation
- define nucleic acid in the biological sample
- describe oligonucleotides as primers and/or probes
- describe primers to distinguish drug resistant influenza A
- describe drug resistant strain of influenza virus
- describe oligonucleotide sequence and its variations

### EXAMPLES

- introduce patient and virus
- describe creation of amplicons for pyrosequencing
- describe pyrosequencing
- analyze results of pyrosequencing
- discuss emergence of resistance during treatment
- discuss implications of results

